HOTH
Hoth Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$9.09M
P/E Ratio
—
EPS
$-0.87
Beta
0.60
52W High
$2.12
52W Low
$0.50
50-Day MA
$0.94
200-Day MA
$1.22
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Hoth Therapeutics Inc
Hoth Therapeutics, Inc., a biopharmaceutical company, is focused on developing therapies for dermatological disorders. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-14.10M |
| Operating Margin | 0.00% |
| Return on Equity | -191.40% |
| Return on Assets | -100.90% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.40 |
| Price-to-Book | 1.49 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 0.40 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $16.26M |
| Float | $15.70M |
| % Insiders | 2.89% |
| % Institutions | 5.16% |
Data last updated: 4/8/2026